Test 7 Emulsions/ Flashcards

1
Q

What is the name of two things that totally mix

A

Solution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What two things are needed to make a solution

A

Solute and solvent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Factors that suggest that suspension is unstable

A

Aggregation
Sedimentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Substance distributed

A

Dispersed phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is another name for vehicle

A

Dispersing phase or dispersing medium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What makes a dispersed system

A

Dispersed phase and dispersing medium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List desirable properties of oral suspension

A

No grittiness
Uniform dispersion
Easy to pour but not watery
Particles should settle slowly
Readily redispersed when shook
Flocculated suspension
Palatable, good odour and colour
Insensitive to temp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Desirable suspeensions for injections

A

Synringeabiltiy
Sterile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Desirable characteristics for opthalmic susp

A

Smaller than 10um
Sterile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Desirable characteristics for topical

A

Fine particles avoid grittiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe sedimentation behaviour

A

Settling of particles/floccules due to gravity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ways of decreasing velocity

A

Smaller particle size
Increases viscosity and density of dispersion medium
Decrease density if dispersed phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do we ensure that a suspension is permanently well dispersed

A

Ask patient to shake bottle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Relationship between particle size wnd velocity

A

Directly proportional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Relationship between density dispersed and dispersion media wnd velocity

A

Directly proportional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Relationship between viscosity of dispersion medium wnd velocity

A

Inversely proportional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Define deflocculation

A

No flocs dominating repulsion forces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define flocculations

A

Flocs formed attracting forces dominate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Repulsive forces are a result of

A

Electrostatic forces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the effect of neutral forces in APIs

A

More van der waals attraction that electrostatic = form flocs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the effect of charge in APIs

A

Electrstatic forces dominate=deflocs= cannot be easily redispersed due to repulsion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How would you know the difference between a flocculated and deflocc solution by looking at it

A

Flocc top layer will be clear
Defloc top layer cloudy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

In a deflocc solution why is the top of the solution cloudy

A

Due to repulsive forces, and stokes law, sedimentation of larger psrticles happens first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Explain flocculation

A

Weak bonds forming fluffy conglomerates
Settle rapidly but will jot form a cake
Easily resuspended
Clear supernatant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Describe the speed of flocculated suspension
More rapid than deflocculated
26
What dies sedimentation depend on
Size and porosity if flocs
27
Describe energy in deflocculation
High repulsive energy
28
Aggregation of particles in deflocculation
Caking
29
Describe supernatant in deflocculation
Turbid supernatant
30
Describe speed of sedimentation in deflocculation
Rate of sediment slow with larger particles sedimenting first
31
In flocculated suspensions what particles settle first
All particles of size settle at same speed
32
In terms of particles explain the difference between flocculated and deflocculated system
Defloc remain independent Flocc particles link together to form loose structure
33
In terms of sedimentation state the difference between floc and defloc solution
Floc - all sediment at same speed in loose structure Deflo- large sediment first but slowly
34
In terms of supernatant describe different between flocculated and defloc system
Defloc- supernatant turbid for long time Floc- supernatant quickly becomes clear
35
In relation to dispersion, compare floc and defloc system
Defloc- may form hard cake irreversible Floc- sediment remains loose and easy to redisperse
36
What does the sediment volume of ratio show
Qual knowledge physical stabiliy of suspension
37
Equation for sediment of volume ratio
Volume of sediment /total volume
38
How can flocculation be controlled
Electrolytes- electrostatic stabilisation Polymers - steric stabilisation
39
How are electrostatic electrolytes used in cotrolled flocculation
Electrolyte decrease the zeta potential
40
How are polymers used in controlled flocculation
Work by absorption Hydrophilic polymers such as cellulose alginates acacia gelatin sodium oleate
41
Which forces lead to attractive interactions between two identically charge oarticles
VDW
42
A flocculated suspension is associated with
A large sediment volume and a clear supernatant
43
What property is a characteristic of deflocc suspension
Close packing of sediment to form a cake
44
What will enhance yhe stability of a drug suspension
Reducing particle size and increasing the viscosity of the suspension
45
How are drugs approved
Benefits are deemed to outweigh their risks
46
Are drugs safe
No all drugs have risks many are serious
47
Do OTC drugs have risks
Yes although fairly rare
48
How does the patient evaluate benefit and risks
Personal values
49
How does the HCP evaluate benefit and risks
Risks for the patient
50
How does the MHRA evaluate benefit and risks
Risks for population
51
What does the mhra stand for
Medicine and healthcare product regulatory agency
52
Describe the rofecoxib scandal
Approve for arthiritis but increased risk if heart attack
53
Explain the effect of drug advertising on individuals
More exposure to meds which gives an impression of greater safety than actually exists Take meds to maintain health
54
Definition of adverse drug reaction
Any harmful effect caused by admin of drug at NORMAL DOSAGE during NORMAL USE
55
Define risk/benefit ratio
Exposure to personal risk is recognise as a normal aspect of everyday life. We acceprs a certain level of risk in our lives as necessary to aschieve certain benefits
56
Frequency of ADR Very common
10% or 1 in 10
57
Frequency of ADR Common
1% to 10% 1 in 10 to 1 in 100
58
Frequency of ADR Uncommon
0.1% to 1% 1 in 100 to 1 in 1000
59
Frequency of ADR Rare
0.01 to 0.1 1 in a 1000 to 1 in 10,000
60
Frequency of ADR Very rare
Less than 0.01% to less than 1 in 10,000
61
What is pharmacovigilance also known as
Post marketing surveillance
62
Major goal of pharmacovigilance
Detect a signal on an unkowm serious adverse drug reaction ASAP Obtain additional info unknown to marketing
63
Effect of pharmacovigilance on labelling and pateint
Improve labelling of drug Improve patient care and patient safety
64
Limitations of clinical trials
Limited no of patients Narrow population Narrow indications Short duration No pregnancy Concomitant meds controlled
65
What action can be taken from pharmacovigilance findings
Restriction in use Changes in dose of med Introduce specific warning Change legal status of med from otc to pom Product recall
66
International collabs for reporting meds
WHO Eu union- EMA Fda in us Uk MHRA- yellow card scheme
67
Where are yellow carss completed
Online and in the BNF
68
What does rhe yellow card scheme act as
Early warning system for identification of unrecognised reactions
69
What does the yellow card scheme collect information from
Side effects Medical devices Defective meds Fake meds Safety concerns from e cigs
70
What ADRs should be reported
Death or serious illness Minor risk with new medicine Minor risk if associate with a child or in pregnancy
71
What does black triangle mean on BNF
New Drug monitored closely for minimum of two years black triangle not removed until safety of drug is established
72
ADR can result in the following:
Result in death Life threatening Requires hospitalisation Disability Congenital anomaly or birth defect Medically significant
73
Who can report ADRs
Patients /relatives HCPs Pharma companies Authority Any member of general public
74
What does pharmacovigilance heavily rely in
Passive surveillance
75
In terms of discipline what is pharmacovigilance
Dynamic clinical and scientific discipline
76
How is a drug deemed successful
Promise invitro demonstrating a beneficial effect in animal and models as well as pass through 3 phases of human clinical trials
77
Difference between invitro and in vivo
Invitro in cells In vivo in life
78
What is formulation
Putting compound in suitable vehicle
79
How do you test stability
Different temperatures and humidity Making sure that nothing happens to the drug
80
What does phase 1 test
Safety in humans
81
What does phase 2 test
Efficacy in patients
82
What does phase 3 test
Safety and efficacy larger scale
83
What does phase 0 test for
Effect on body
84
What does phase 4 test for
Long term safety
85
IMPD
Investigational medicinal product dossier Certifies approval for clinical trials to take place
86
MAA
Marketing authorisation application Must be approves at the end of clinical trials Equivalent to NDA
87
EMA
European medicine agency Revies the commercialised products
88
Why are new drugs needed
Unmet medical need Cost of therapy Sustain industrial activity
89
Explain the unmet medical need
New diseases Low efficacy such as dementia and cancer Side effects of antidepressants/ antipsychotics
90
Purpose of drug patents
Protect ideas in pharmaceutical company
91
Definition of formulation science
Transforming API into a quality drug product in a specific dosage form
92
Purpose of formulation
For stability ease of administration or patient acceptability
93
What does formulating a drug and excipients into a dosage form allow
Manipulation of dosing frequency
94
How is choice of formulation important
When dealing with vulnerable populations eg children elderly
95
What does preformulation study involve
Characterisation of api eg solubility/melting point Investigation fo physicochemical properties alone and with excipients
96
Choosing quant formula and process is also known as
Formulation development
97
Transferring the process from lab to industrial is known as
Scale up and process validation
98
Learning before doing is…
Pre-formulation studies
99
What do drug discovery and preclinical trials involve
Preformulation Formulation support for preclinical test Developing a formulation for clinical trials
100
What do clinical trials involve
Scaleup activities Ontime supply of clinical trial material Formulation development
101
Post marketing surveillance can lead to..
Reformulation 2nd generation launch Pom to otc
102
Preformulation main areas of focus regarding physicochemical properties
Organoleptic properties- colour/odor/taste Particles size and shapes-solubility Purity-impurtities can be toxic Surface area - solubility and dissolution
103
Preformulation main areas of focus regarding Bulk characteristics
Crystallinity and polymorphism- stability and compatibility Bulk density- measure volume / weight Powder flow properties Hygroscopicity- how much water absorbed from air
104
Preformulation main areas of focus regarding Solubility studies
Aqueous solubility - must dissolve in git prior to absorption Ph solubility Log p- drug across membrane Dissolution
105
Preformulation main areas of focus regarding Stability studies
Solid state- stable storage conditions snd investigate effect of pH:/ cosolvent/ temp/light Solution Bulk Compatibility - look at interaction with other drugs
106
What are drug candidates becoming
More lipophilic and poorly soluble
107
What does the comprehensive report include
Problems associated with molecule
108
Formulation studies involve
Delivery of robust and stable drug product formulations that consistently deliver the desired API:
109
List the steps of formulation studies
Formulation design Process development Formulation support for preclinical test Clinical trials Scale up Package development Ongoing stability studies
110
How did covid develop quickly
Funding Urgency Demand
111
How did covid vaccine trigger immune system
Spike protein
112
How did covid get approved quickly
Temp approval for specific batches of pfizer vaccine based on efficacy Rolling revies process
113
Why was covid vaccine temporary
Dont need eu approval Approval for 1 year Allow companies to continue studies and submit evidence
114
Where can you find information for drug disposal
EMC Patient leaflet
115
What are preclinical trials
Non clinical studies is the stage of research that begins before testing in humans
116
What is the purpose of pre clinical trials
Determine a products ultimate safety profile
117
In preclinical trials, what is the main purpose
Test drugs and devices to see if theyre safe and effective
118
What types of products are used in preclinical tests
New drugs Medical devices Gene therapy solutions
119
What do individuals consider before taking medication
Effectiveness Doee How often Side effects Any interactions Is it a cure
120
Main aim of preclinical trials
Gather enough info to decide whether drug is safe to proceed with human trials
121
Animals used in preclinical trials
Zebra fish Mice and rodent models Rabbits Fruit fly
122
List importance of preclinical trials
Determine dose, toxic dose , pharmacological action , Requirement if reg body Consider ethical viewpoint Kinetic profile Effective route if admin
123
In general animal studies are conducted in two species
Rodent Non rodent
124
How are safety pharmacology studies used in preclinical studies
Determine the effects of drug on specialised organ system
125
How are carcinogenicity studies used in preclinical studies
Determine effects of long term exposure to drug including ability to produce cancer Not used for short term use drugs
126
How are reproductive toxicity studies used in preclinical studies
Evaluate effects on reproductive function & ability to produce birth defects
127
List the 3 types of scientific models used
Insilico- computational modelling Invitro in test tube In living animals In living humans
128
Non animal and non humans models
In silico and in vitro
129
Conditions of in vitro experimentation
Aseptic techniques Biosafety cabinet Cells grown at 37c and 5% co2
130
Journey of in vitro experiment
Grow cells in flask Then add to 96 well plate Then plot IC50
131
Pros and cons of in vitro models
Less expensive than in vivo Faster than in vivo Difficult to mimic complex physio environments
132
What do screening models test in vitro models
Cytotoxicity Protein binding Cyp inhibition/induction Membrane permeability
133
What is a model organism
Non human species studies used to provide insight into working of other organisms
134
Why are mouse models favoured
Close model to humans High degree of genetic similarity
135
Why are c elegans favoured
Grown and manipulated with speed and ease but includes key complex features of an organism
136
Fruit fly
Easy to manipukaye Used to study development, physio and behaviour Well conserved genes -homologues
137
Why are Zebra fish used as animal model
Small size short life cycle Readily produce mutations relevant to human health and disease Embryonic development
138
Disadvantages of animal models
Lack of appropriate drug target in preclinical animal model Irrelevant target Difference in metabolism Unethical
139
Animal trials…
Are not always predictive
140
Ethical considerations in animal studies
Refinement- minimise pain and suffering Reduction- using a few animals as possible Replacement- use other models
141
Alternatives to animal models
In vitro or computational modelling by law if as effective as using animals Use lowest animal eg fly rather than mouse
142
Study details of preclinical trials
Only few out of thousands reach stage Safety in at least two animal species Oral and parenteral routes
143
What are screening test
Simple and rapid test performed to indicate presence or absence of a particle pharmacodynamic activity
144
What are tests on isolated organs, bacterial cultures
Preliminary tests to detect specific activity, eg antihistaminic/ antisecretory
145
What are tests on animal models of human disease
Animals to study different type of drugs
146
What is a general observational test
Drug injected in 3 doses to small group which are observed for hidden effects
147
What are confirmatory tests and analogous activities
Test for active compounds
148
What are mechanism of action studies
Attempt to find our mechanism of action
149
What is systemic pharmacology
Effect of drug on major organ systems
150
What are quantitave tests
Dose response relationship, maximal effects
151
What are pharmacokinetic test
Absorprion, tissue distribution, metabolism, excretion
152
IND
Investigational new drug How drug is manufactured Appears Formulation intended Analysis for purity/concentration and stability Safety
153
Common technical document
Set of spec containing all the quality safety and efficacy information Used with other ICh and reg agency MHRA